Screening with AI
is genius.

Alert Indications, Safety, and Warnings

The future of preventative health is a GI Genius™ colonoscopy, powered by AI.

The Gl Genius™ intelligent endoscopy module isn't replacing doctors but empowering them.​

With the accuracy of AI, doctors can detect and address polyps or growths of various sizes, shapes, and morphologies, significantly improving early detection rates and helping them stop colorectal cancer before it starts.2

Understand why early colorectal cancer (CRC) screenings are important.



The 5-year
relative survival rate
for patients
diagnosed early is

90%.3

Screening can prevent colorectal cancer.3

 

 

Find a GI Genius™ doctor.

Take advantage of the benefits of artificial intelligence (AI) screening.

A medical professional poses for a photo with her arms crossed

Why schedule your AI-assisted colon cancer screening?

The GI Genius™ module has been shown to increase detection of colorectal polyps, which can be precancerous growths.2

See a side-by-side comparison of a CRC screening with and without the GI Genius™ module.

Information and resources on this site should not be used as a substitute for medical advice from your doctor. Always discuss diagnosis and treatment information including risks with your doctor. Keep in mind that all treatment and outcome results are specific to the individual patient. Results may vary.

Indications

GI Genius™ intelligent endoscopy module is a computer-assisted reading tool designed to aid endoscopists in detecting colonic mucosal lesions (such as polyps and adenomas) in real time during standard white-light endoscopy examinations of patients undergoing screening and surveillance endoscopic mucosal evaluations. The GI Genius computer-assisted detection device is limited for use with standard white-light endoscopy imaging only. This device is not intended to replace clinical decision making.

Risk information

GI Genius™ intelligent endoscopy module is intended to be used as an accessory to colonoscopy procedures and is not intended to replace endoscopist assessment or histopathological sampling. The system does not perform any diagnosis and is not intended to be used as a stand-alone diagnostic device. The device has not been studied in patients with inflammatory bowel disease (IBD), history of colorectal cancer, or previous colonic resection. The device performance may be negatively impacted by mucosal irregularities such as background inflammation from certain underlying diseases. Use of GI Genius™ intelligent endoscopy module during colonoscopy may present risks related to identification of lesions. Risk of identification of a false lesion may result in unnecessary patient treatment, or failure to identify a lesion resulting in delayed patient treatment. All medical procedures carry risks. Please refer to your physician for more information about procedure risks related to colonoscopy and those related to GI Genius™ intelligent endoscopy module.

1

Ahmed M. Colon Cancer: A Clinician’s Perspective in 2019. Gastroenterology Research. 2020;13(1):1–10.

2

Repici A, Badalamenti M, Maselli R, et al. Efficacy of real-time computer-aided detection of colorectal neoplasia in a randomized trial. Gastroenterology. 2020;159:512–520.e7.

3

Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London, England). 2014;383(9927):1490–1502.